ChinaBio Today -- ProMetic Life Sciences has completed the first milestone in its strategic collaboration with the Wuhan Institute of Biological Products (WIBP), a subsidiary of China National Pharmaceutical Group Corp (Sinopharm). ProMetic has licensed its proprietary protein technologies to Sinopharm, with the goal of allowing WIBP to produce biosimilar drug products. More details...
